Efficacy of curcumin on prevention of drug-induced nephrotoxicity: A review of animal studies
MetadataShow full item record
Drug-induced nephrotoxicity is a frequent serious adverse effect, contributing to morbidity and increased healthcare utilization. Prevention or reversal is key. Curcumin has useful biological features that include antioxidant, anti-inflammatory, and anticancer properties. This review covers aspects of curcumin in relation to prevention of drug-induced nephrotoxicity: dosage and schedule, effect on kidney biomarkers and histological changes, and mechanisms of curcumin's protective effects. Despite success in some animal models, human studies and clinical administration of curcumin for nephroprotection remains limited due to difficulty in achieving therapeutic levels following oral administration and in determining the optimal dosing schedule. Lack of sufficient evidence from animal studies, coupled with low systemic bioavailability, continues to limit the utilization of curcumin in addressing and controlling drug-induced nephrotoxicity. Therefore, human studies are required to fully assess and validate the therapeutic potential of curcumin. © 2019 International Union of Biochemistry and Molecular Biology
Showing items related by title, author, creator and subject.
Curcumin as a therapeutic candidate for multiple sclerosis: Molecular mechanisms and targets (2020) Ghanaatian N.; Lashgari N.-A.; Abdolghaffari A.H.; Rajaee S.M.; Panahi Y.; Barreto G.E.; Butler A.E.; Sahebkar A. (Wiley-Liss Inc., 2019)
Role of a RhoA/ROCK-dependent pathway on renal connexin43 regulation in the angiotensin ii-induced renal damage (2020) Gómez G.I.; Velarde V.; Sáez J.C. (MDPI AG, 2019)
ReviewBavarsad K.; Barreto G.E.; Hadjzadeh M.-A.-R.; Sahebkar A. (Humana Press Inc., 2019)